NATIONAL INSTITUTE OF TECHNOLOGY, HAMIRPUR CHEMICAL ENGINEERING DEPARTMENT DISCOVERY THAT MATURE CELLS CAN BE REPROGRAMMED TO BECOME PLURIPOTENT SEMINAR REPORT CH-327 NAME: MAYANK BHARDWAJ ROLL NUMBER: 20BCH051 DISCOVERY THAT MATURE CELLS CAN BE REPROGRAMMED TO BECOME PLURIPOTENT ABSTRACT The discovery of iPSCs has paved the way for numerous applications in the medical field, including the use of patient-specific iPSCs to model diseases, the development of new drugs, and the creation of personalized cell-based therapies. Additionally, the ability to reprogram cells without the use of embryos has removed many ethical considerations associated with traditional stem cell research. Overall, the discovery of reprogramming mature cells has opened up new avenues of research and holds immense promise for future medical treatments. 1. INTRODUCTION Pluripotency refers to the ability of a cell to differentiate into any type of cell in the body. Pluripotent cells are considered the building blocks of the body and have the potential to form any tissue or organ. This unique property makes them of great importance in the field of biology and medicine. In biology, pluripotent cells provide a valuable tool for understanding cellular differentiation and the development of tissues and organs. In medicine, pluripotent cells hold immense promise for regenerative therapies and disease treatment. For example, scientists can use pluripotent cells to generate replacement tissues and organs, thereby providing new treatments for conditions such as heart disease, diabetes, and spinal cord injury. Additionally, the ability to generate patient-specific pluripotent cells has allowed scientists to study the underlying causes of diseases and develop new drugs. Overall, pluripotency and the study of pluripotent cells are crucial for advancing our understanding of biology and for developing new medical treatments. The study of stem cells has a long and rich history that dates back to the early 20th century. In the early days of stem cell research, scientists were primarily interested in the role of stem cells in embryonic development. In the 1950s and 1960s, the discovery of stem cells in adult tissues opened up new avenues of research and sparked interest in the potential therapeutic applications of these cells. In the late 20th and early 21st centuries, advances in cell culture techniques and genetic engineering paved the way for the discovery of induced pluripotent stem cells (iPSCs). In 2006, scientists showed that mature cells could be reprogrammed to become pluripotent, setting the stage for a new era of stem cell research. Since the discovery of iPSCs, the field of stem cell research has expanded rapidly, leading to numerous scientific and medical breakthroughs. Today, stem cell research is a highly active and interdisciplinary field that brings together scientists from diverse backgrounds, including biology, medicine, and engineering. Overall, the historical context of st

1. NATIONAL INSTITUTE OF TECHNOLOGY, HAMIRPUR
CHEMICAL ENGINEERING DEPARTMENT
DISCOVERY THAT MATURE CELLS CAN BE
REPROGRAMMED TO BECOME PLURIPOTENT
SEMINAR REPORT
CH-327
NAME: MAYANK BHARDWAJ
ROLL NUMBER: 20BCH051

2. DISCOVERY THAT MATURE CELLS CAN BE
REPROGRAMMED TO BECOME PLURIPOTENT
ABSTRACT
The discovery of iPSCs has paved the way for numerous applications in the medical field,
including the use of patient-specific iPSCs to model diseases, the development of new drugs, and
the creation of personalized cell-based therapies. Additionally, the ability to reprogram cells
without the use of embryos has removed many ethical considerations associated with traditional
stem cell research.
Overall, the discovery of reprogramming mature cells has opened up new avenues of research
and holds immense promise for future medical treatments.
1. INTRODUCTION
Pluripotency refers to the ability of a cell to differentiate into any type of cell in the body.
Pluripotent cells are considered the building blocks of the body and have the potential to form
any tissue or organ. This unique property makes them of great importance in the field of biology
and medicine.
In biology, pluripotent cells provide a valuable tool for understanding cellular differentiation and
the development of tissues and organs. In medicine, pluripotent cells hold immense promise for
regenerative therapies and disease treatment. For example, scientists can use pluripotent cells to
generate replacement tissues and organs, thereby providing new treatments for conditions such as
heart disease, diabetes, and spinal cord injury. Additionally, the ability to generate
patient-specific pluripotent cells has allowed scientists to study the underlying causes of diseases
and develop new drugs.

3. Overall, pluripotency and the study of pluripotent cells are crucial for advancing our
understanding of biology and for developing new medical treatments.
The study of stem cells has a long and rich history that dates back to the early 20th century. In
the early days of stem cell research, scientists were primarily interested in the role of stem cells
in embryonic development. In the 1950s and 1960s, the discovery of stem cells in adult tissues
opened up new avenues of research and sparked interest in the potential therapeutic applications
of these cells.
In the late 20th and early 21st centuries, advances in cell culture techniques and genetic
engineering paved the way for the discovery of induced pluripotent stem cells (iPSCs). In 2006,
scientists showed that mature cells could be reprogrammed to become pluripotent, setting the
stage for a new era of stem cell research.
Since the discovery of iPSCs, the field of stem cell research has expanded rapidly, leading to
numerous scientific and medical breakthroughs. Today, stem cell research is a highly active and
interdisciplinary field that brings together scientists from diverse backgrounds, including
biology, medicine, and engineering.
Overall, the historical context of stem cell research highlights the important role that stem cells
play in our understanding of biology and medicine and the potential for these cells to
revolutionize medical treatments in the future.
2. THE DISCOVERY OF REPROGRAMMING MATURE CELLS
2.1 Explanation of induced pluripotent stem cells (iPSCs)
Induced pluripotent stem cells (iPSCs) are cells that have been reprogrammed from mature,
specialized cells back to a pluripotent state. Pluripotent cells have the ability to differentiate into
any type of cell in the body, making them a valuable tool for regenerative medicine and disease
modeling.

4. The process of creating iPSCs involves the introduction of specific genes into mature cells using
genetic engineering techniques. These genes can be delivered using viral vectors or other
methods. The reprogrammed cells are then induced to form iPSCs, which have the ability to
differentiate into various cell types.
The discovery of iPSCs has had a profound impact on the field of biology and medicine. The
ability to generate patient-specific iPSCs has allowed scientists to study the underlying causes of
diseases and develop new drugs. Additionally, iPSCs have the potential to be used in
regenerative medicine, as they can be induced to differentiate into replacement tissues and
organs.
Overall, iPSCs represent a promising new tool for understanding cellular biology and developing
new medical treatments. The study of iPSCs continues to be an active area of research, with
many new discoveries and advances expected in the coming years.
2.2 Discovery of the process to revert mature cells back to a pluripotent state
The discovery of the process to revert mature cells back to a pluripotent state was a major
milestone in the field of stem cell research. The discovery was made by a team of scientists led
by Dr. Shinya Yamanaka of Kyoto University in Japan.
In 2006, Dr. Yamanaka and his team showed that mature cells could be reprogrammed to a
pluripotent state by introducing four specific genes into the cells. The four genes, Oct4, Sox2,
Klf4, and c-Myc, are known to be important for maintaining pluripotency in embryonic stem
cells. When these genes were introduced into mature cells, the cells were converted back to a
pluripotent state, which allowed them to differentiate into any type of cell in the body.
The discovery of the process to revert mature cells back to a pluripotent state was a major
breakthrough in the field of stem cell research, as it provided a new tool for understanding
cellular biology and developing new medical treatments. The discovery was recognized with the
2012 Nobel Prize in Physiology or Medicine, which was awarded to Dr. Yamanaka for his work.

5. Since the discovery, the field of induced pluripotent stem cells (iPSCs) has grown rapidly,
leading to numerous scientific and medical breakthroughs. The ability to generate
patient-specific iPSCs has allowed scientists to study the underlying causes of diseases and
develop new drugs, while the potential for iPSCs to be used in regenerative medicine continues
to be a major focus of ongoing research.
3. APPLICATIONS OF iPSCs
3.1 Patient-specific iPSCs for disease modeling
Patient-specific induced pluripotent stem cells (iPSCs) are cells that have been created from the
cells of a specific patient. The ability to generate patient-specific iPSCs has allowed scientists to
study the underlying causes of diseases and develop new drugs in a way that was not possible
before.
One of the key advantages of patient-specific iPSCs is that they provide a unique opportunity to
study the effects of diseases in a controlled and highly representative system. For example,
scientists can generate iPSCs from patients with a particular disease and then differentiate the
cells into the specific cell type affected by the disease. This allows them to study the disease in a
laboratory setting and identify new therapeutic targets.
In addition, patient-specific iPSCs can be used to develop new drugs and test their efficacy in a
highly controlled and representative system. This can help to speed up the drug development
process and reduce the risk of failed clinical trials, as well as improve the chances of developing
new drugs that are effective for a large number of patients.
Overall, patient-specific iPSCs represent a valuable tool for disease modeling and drug
development, and are helping to revolutionize the way we study and treat diseases. The study of
patient-specific iPSCs continues to be an active area of research, with many new discoveries and
advances expected in the coming years.
3.2 Development of new drugs

6. The development of new drugs is a critical aspect of modern medicine, as it provides a means to
treat and cure diseases. The discovery of induced pluripotent stem cells (iPSCs) and the ability to
generate patient-specific iPSCs has had a significant impact on the development of new drugs.
One of the key benefits of iPSCs is that they can be used to develop in vitro models of disease,
allowing scientists to study the underlying causes of diseases and test new drugs in a controlled
and representative system. This can help to speed up the drug development process and reduce
the risk of failed clinical trials, as well as improve the chances of developing new drugs that are
effective for a large number of patients.
In addition, patient-specific iPSCs provide a unique opportunity to study the effects of diseases
in a highly representative system, allowing scientists to identify new therapeutic targets. This
information can then be used to develop new drugs that are specifically targeted to the
underlying causes of the disease, increasing the chances of success in treating the disease.
Overall, iPSCs and patient-specific iPSCs are providing a valuable new tool for the development
of new drugs, and are helping to revolutionize the way we study and treat diseases. The study of
iPSCs and their use in drug development continues to be an active area of research, with many
new discoveries and advances expected in the coming years.
3.3 Creation of personalized cell-based therapies and Advancements in regenerative
medicine
The discovery of induced pluripotent stem cells (iPSCs) and the ability to generate
patient-specific iPSCs has had a major impact on the field of regenerative medicine. One of the
key goals of regenerative medicine is to develop new treatments that can repair or replace
damaged or diseased cells, tissues, and organs.
The ability to generate patient-specific iPSCs has opened up new possibilities for the creation of
personalized cell-based therapies. For example, iPSCs can be differentiated into specific cell
types, such as neurons, heart cells, or liver cells, and then used to replace damaged or diseased

7. cells in the body. This has the potential to provide new treatments for a wide range of diseases,
including neurodegenerative diseases, heart disease, and liver disease, among others.
In addition, iPSCs provide a valuable tool for the study of human development and disease,
allowing scientists to better understand the underlying causes of disease and develop new
treatments. The study of iPSCs continues to be an active area of research, with many new
discoveries and advances expected in the coming years.
Overall, the discovery of iPSCs and the ability to generate patient-specific iPSCs is a major step
forward in the field of regenerative medicine, and holds great promise for the development of
new treatments for a wide range of diseases. The use of iPSCs in regenerative medicine
continues to be an active area of research, with many new discoveries and advances expected in
the coming years.
4. ETHICAL CONSIDERATIONS
4.1 Use of embryos in Traditional Stem Cell Research
Traditional stem cell research has often involved the use of embryos as a source of stem cells.
Embryonic stem cells are pluripotent cells that have the ability to differentiate into any cell type
in the body. This makes them a valuable tool for understanding human development and disease,
as well as for developing new treatments.
However, the use of embryos in stem cell research has been a source of ethical controversy, as it
requires the destruction of human embryos. This has led to a debate about the morality of using
embryos in research and has limited the funding and support for this type of research in some
countries.
Despite these ethical concerns, many scientists believe that embryonic stem cell research is
essential for advancing our understanding of human development and disease and for developing
new treatments. In response to the ethical concerns, alternative sources of stem cells, such as

8. induced pluripotent stem cells (iPSCs), have been developed, which provide a way to generate
pluripotent cells without the use of embryos.
Overall, the use of embryos in traditional stem cell research remains a controversial issue, with
opinions on the matter varying widely among scientists, policymakers, and the general public.
Nevertheless, the study of stem cells, including embryonic stem cells, continues to be an
important and active area of research, with many new discoveries and advances expected in the
coming years
4.2 The Ethical Implications of iPSC Research
The use of induced pluripotent stem cells (iPSCs) in research has the potential to greatly advance
our understanding of human development and disease, as well as to provide new treatments for a
wide range of conditions. However, the use of iPSCs also raises a number of ethical
considerations that need to be taken into account.
One of the key ethical implications of iPSC research is the issue of informed consent. In order to
generate iPSCs, a small sample of cells, such as skin cells, is needed from the individual. This
raises the question of whether the individual giving the cells is fully informed about the use of
their cells and whether they have given their informed consent.
Another ethical consideration is the potential for the misuse of iPSCs, such as the creation of
human clones or the use of iPSCs in research that may be seen as unethical. This raises the need
for appropriate regulation and oversight of iPSC research to ensure that it is conducted in an
ethical and responsible manner.
In addition, the use of iPSCs in research may raise concerns about the commercialization of
medical treatments and the affordability of new treatments for all individuals. This raises the
need for careful consideration of the economic and social implications of iPSC research and the
development of new treatments.
Overall, the use of iPSCs in research is a complex and controversial issue, with a range of ethical
considerations that need to be taken into account. It is important that iPSC research is conducted

9. in an ethical and responsible manner, with appropriate regulation and oversight, to ensure that
the potential benefits of iPSC research are realized while minimizing the risks and ethical
concerns associated with this type of research.
5. CONCLUSION
Induced pluripotent stem cells (iPSCs) have the potential to revolutionize medical treatments by
providing a new and powerful tool for understanding human development and disease and for
developing new treatments for a wide range of conditions.
One of the key benefits of iPSCs is that they can be generated from a patient's own cells, which
eliminates the risk of rejection that can occur with traditional transplantation therapies. This
opens the door to the development of personalized cell-based therapies that are tailored to the
specific needs of each patient.
In addition, iPSCs provide a valuable tool for disease modeling and drug discovery. Researchers
can use iPSCs to study the underlying causes of diseases, such as genetic mutations and cellular
abnormalities, and to test the effectiveness of new drugs in a controlled, laboratory setting. This
can greatly accelerate the pace of drug discovery and the development of new treatments.
Another important benefit of iPSCs is that they can be used to study the development of rare and
hard-to-treat diseases, as well as to develop new treatments for conditions that currently have
limited or no effective treatments available.
Overall, the potential for iPSCs to revolutionize medical treatments is vast and the possibilities
are only limited by our imagination and our ability to advance the technology. While there are
still many challenges and obstacles to overcome, the future of iPSC research is promising, and
the potential benefits to human health are immense.
REFERENCES

10. 1. Brennand KJ, Simone A, Jou J,Gelboin-Burkhart C, Tran N, Sangar S et al (2011).
Modeling schizophrenia using human induced pluripotent stem cells.Nature 473:
221-225.
2. Briggs R, King TJ (1952). Transplantation of Living Nuclei from Blastula Cells into
Enucleated Frog's Eggs. Proc Natl Acad Sci USA 38:455-463.
3. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S et al (2003).
Functional expression cloning of Nanog, a pluripotency sustaining factor in
embryonic stem cells. Cell 113:643-655.
4. Davis RL, WeintraubH, Lassar AB (1987). Expression of a single transfected cDNA
converts fibroblasts tomyoblasts.Cell 51:987-1000.
5. Elsdale TR,Fischberg M,Smith S (1958).A Mutation That Reduces Nucleolar
Number in XenopusLaevis.Exp Cell Res 14:642-643.
6. Hochedlinger K, Jaenisch R (2002).Monoclonal mice generated by nuclear transfer
from mature B and T donor cells. Nature 415:1035-1038.
7. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG et al (2010).
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined
factors.Cell 142:375-386.
8. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA et al (2009).
Modeling pathogenesis and treatment of familial dysautonomia using patient-specific
iPSCs. Nature 461:402- 406.
9. Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T et al (2009).Generation of
human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27:
2992-3000.

11. 10. Song KH, Nam YJ, Luo X, Qi XX, Tan W, Huang GN et al (2012). Heart repair by
reprogramming nonmyocytes with cardiac transcription factors. Nature 485:599-604.
11. Tada M, Takahama Y, Abe K,Nakatsuji N,Tada T (2001). Nuclear reprogrammingof
somatic cells by in vitro hybridization with ES cells. CurrBiol 11:1553-1558.
12. Takahashi K,Mitsui K,Yamanaka S (2003).Role of ERas in promoting tumor-like
properties in mouse embryonic stem cells. Nature 423:541-545.
13. Waddington CH (1957). The Strategy of the Genes; a Discussion of Some Aspects
of Theoretical Biology. Allen&Unwin.